Bank of Montreal’s Aldeyra Therapeutics ALDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-80,700
Closed -$324 4047
2022
Q2
$324 Buy
+80,700
New +$278K ﹤0.01% 2965
2021
Q3
Sell
-32,257
Closed -$383K 3795
2021
Q2
$383K Buy
32,257
+21,430
+198% +$258K ﹤0.01% 2965
2021
Q1
$136K Sell
10,827
-298,411
-96% -$3.44M ﹤0.01% 3260
2020
Q4
$3.17M Sell
309,238
-89,011
-22% -$625K ﹤0.01% 1601
2020
Q3
$2.85M Buy
398,249
+395,722
+15,660% +$2.56M ﹤0.01% 1505
2020
Q2
$13K Buy
+2,527
New +$9.23K ﹤0.01% 4030
2020
Q1
Sell
-2,887
Closed -$17K 4061
2019
Q4
$17K Buy
2,887
+909
+46% +$5.25K ﹤0.01% 4380
2019
Q3
$10K Sell
1,978
-159
-7% -$856 ﹤0.01% 4398
2019
Q2
$12K Buy
2,137
+2,135
+106,750% +$16.1K ﹤0.01% 4435
2019
Q1
$0 Sell
2
-298
-99% -$2.53K ﹤0.01% 4278
2018
Q4
$2K Buy
300
+182
+154% +$1.86K ﹤0.01% 4336
2018
Q3
$2K Buy
118
+5
+4% +$41 ﹤0.01% 4311
2018
Q2
$1K Buy
+113
New +$902 ﹤0.01% 4486

Other funds holding ALDX

Bank of Montreal's ALDX Position: Q3 2022 in Review

Bank of Montreal sold out of Aldeyra Therapeutics (ALDX) in Q3 2022, closing a stake of 80,700 shares — an estimated $324 sold.

Bank of Montreal first reported a position in ALDX in Q2 2018 and held it in 13 quarters. The position peaked at $3.17M in Q4 2020. 89 funds tracked by Wall St. Rank hold ALDX as of Q3 2022.

  • Bank of Montreal reported no remaining Aldeyra Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Bank of Montreal sold 80,700 Aldeyra Therapeutics shares in Q3 2022, an estimated $324.
  • Bank of Montreal first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 13 quarters.
  • Bank of Montreal's Aldeyra Therapeutics position peaked at $3.17M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.